Page last updated: 2024-08-26

fulvestrant and plx 4720

fulvestrant has been researched along with plx 4720 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, DJ; Boland, GM; Cichowski, K; Crawford, L; Flaherty, KT; Frederick, DT; Herlyn, M; Krepler, C; Liberti, MV; Liu, X; Locasale, JW; Maertens, O; Magpusao, AN; Manchester, HE; McCall, SJ; Mukherjee, S; Singleton, KR; Sproesser, K; Stein, EM; Tingley, JP; Tsui, E; Wood, KC	1

Other Studies

1 other study(ies) available for fulvestrant and plx 4720

Article	Year
Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence. Cell reports, 2017, Dec-05, Volume: 21, Issue:10 Topics: Antineoplastic Agents, Hormonal; Benzimidazoles; Cell Line, Tumor; Estradiol; Evolution, Molecular; Female; Fulvestrant; Humans; Imidazoles; Indoles; Male; Melanoma; Oximes; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-myc; Pyridones; Pyrimidinones; Quinolines; Signal Transduction; Sulfonamides	2017

Article

Year

Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.

Cell reports, 2017, Dec-05, Volume: 21, Issue:10

Topics: Antineoplastic Agents, Hormonal; Benzimidazoles; Cell Line, Tumor; Estradiol; Evolution, Molecular; Female; Fulvestrant; Humans; Imidazoles; Indoles; Male; Melanoma; Oximes; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-myc; Pyridones; Pyrimidinones; Quinolines; Signal Transduction; Sulfonamides

2017